ArticleScience (New York, N.Y.)2024
AI and biosecurity: The need for governance.
Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Article
- Artificial intelligence and automation in enzyme engineering: evolution, advances, and future perspectives.Bioresources and bioprocessing · 2026Review
- Predicting the evolutionary and functional landscapes of viruses with a unified nucleotide-protein language model: LucaVirus.National science review · 2026Article
- Soft Robotics and Advanced Technologies for Minimally Invasive Bioprinting: The Future of Internal Organ Repair.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Article
- General-Purpose Models for the Chemical Sciences: LLMs and Beyond.Chemical reviews · 2026Review
- Autonomous artificial intelligence, scientific research, and human values.AI and ethics · 2026Article
- Containment of antimicrobial resistance for strengthening global public health security: Biorisk management perspectives.Biosafety and health · 2026Review
- Peptide-based drug design using generative AI.Chemical communications (Cambridge, England) · 2026Review
- Leveraging AI for cell biology discovery.Biochemical Society transactions · 2026Review
- Improving governance in the age of synthetic biology, artificial intelligence, and diverging threats.Frontiers in bioengineering and biotechnology · 2026Article
- The limits of sequence-based biosecurity screening tools in the age of AI-assisted protein design.Frontiers in bioengineering and biotechnology · 2026Article
- China's regulatory regime for medical biotechnology: evolution, challenges, and future perspectives.Frontiers in medical technology · 2026Review
- Review
- Generating functional plasmid origins with OriGen.Nucleic acids research · 2025Article
- Low-N Protein Activity Optimization with FolDE.ArXiv · 2025Article
- Ensuring Biosecurity and Research Agility for Outbreak Response: A Researcher's Perspective on the Federal Nucleic Acid Screening Framework.Applied biosafety : journal of the American Biological Safety Association · 2025Article
- FoldMark: Safeguarding Protein Structure Generative Models with Distributional and Evolutionary Watermarking.bioRxiv : the preprint server for biology · 2025Article
- A call for built-in biosecurity safeguards for generative AI tools.Nature biotechnology · 2025Article
- Virologist Opinions: An Important Component for the Governance of the Convergence of Artificial Intelligence and Dual-Use Research of Concern.Applied biosafety : journal of the American Biological Safety Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Governments should evaluate advanced models and if needed impose safety measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.